Trial Partnerships Exploit the existing alliance with All Points North to expand late-stage trials and design integrated addiction care models, engaging rehab networks as trial sites and early-access channels for patients.

AUD Opportunity The focus on synthetic Mescaline HCl for AUD signals a sizable addressable market; pursue partnerships with payers, health systems, and patient access programs to build evidence of durable remission and advance reimbursement strategies.

Funding Leverage Backed by notable investors including Sam Altman and Apollo Projects; raised significant Series A funding in 2021 and total funding to date supports conversations with strategic pharma partners, CROs, and contract manufacturers for development and manufacturing scale.

Boutique Expertise As a small team with a unique stakeholder structure and an experienced leadership, Journey Colab offers nimble, high-touch collaboration opportunities for larger firms seeking regulatory, clinical development, and commercialization support.

Tech Enabled Trials The tech stack including AWS, Cloudflare, Nginx, and OpenResty indicates capacity to offer scalable digital trial platforms, remote monitoring, data management, and patient engagement services to support psychedelic trials and faster go-to-market.